Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor.
Silver
H
H
Flugelman Psychiatric Hospital, Mazra, Doar Na Ashrat, Israel.
Barash
I
I
Odnopozov
N
N
Jahjah
N
N
Mizruhin
A
A
D000328:Adult; D015415:Biomarkers; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008550:Melatonin / Q000097:blood*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D015415:Biomarkers; D016666:Fluvoxamine; D008550:Melatonin; D017367:Selective Serotonin Reuptake Inhibitors